Catecholamine-Induced Inflammasome Activation in the Heart Following Photothrombotic Stroke

Xavier O Scott1, Nadine A Kerr2,3, Juliana Sanchez-Molano2,3

  • 1Department of Molecular Physiology and Cellular Biophysics, University of Miami Miller School of Medicine, Miami, FL, USA.

PubMed

Insights

Stroke triggers a catecholamine surge, activating the AIM2 inflammasome in the heart. This inflammasome activation and subsequent pyroptosis contribute to cardiac dysfunction, but can be blocked by the inhibitor IC100.

Area of Science:

  • Neuroscience
  • Cardiology
  • Immunology

Background:

  • Cerebrovascular stroke patients often experience cardiac arrhythmias.
  • Post-traumatic cardiac dysfunction is linked to catecholamine surges and inflammation.
  • The role of inflammasome activation in post-stroke cardiac dysfunction is unknown.

Purpose of the Study:

  • Investigate inflammasome activation in post-stroke cardiac dysfunction.
  • Determine the role of catecholamines in this process.
  • Evaluate the efficacy of the inflammasome inhibitor IC100.

Main Methods:

  • Used a mouse model of photothrombotic stroke (PTS).
  • Administered epinephrine to induce catecholamine surge.
  • Recorded action potential duration in excised zebrafish hearts.
  • Assessed inflammasome markers (AIM2, IL-1b, caspase-8).

Main Results:

  • PTS induced AIM2 inflammasome activation in mouse atria and ventricles.
  • Epinephrine injection increased AIM2, IL-1b, and caspase-8 in mouse atria.
  • Epinephrine shortened action potential duration in zebrafish hearts.
  • IC100 treatment reduced inflammasome activation and protected cardiac function.

Conclusions:

  • Stroke-induced catecholamine surge activates the AIM2 inflammasome and pyroptosis in the heart.
  • This pathway contributes to cardiac dysfunction after stroke.
  • IC100 effectively blocks inflammasome activation, offering a therapeutic strategy for stroke-related cardiovascular injury.